ProfileGDS4177 / 209343_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 49% 52% 62% 64% 54% 55% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated31.7549
GSM603099KU-812 non-treated35.5752
GSM603098KCL-22 Imatinib-treated61.1462
GSM603097KCL-22 non-treated66.5364
GSM603102JURL-MK1 Imatinib-treated38.6254
GSM603101JURL-MK1 non-treated40.5455